- Profile
- Personal Information
- Publications
Experts in Nephrology
Jessy J. Alexander Ibrahim Batal Ann Hagan Tanya Hoodbhoy Luis Alfredo Bent-Shaw Stephen Y Nakada Wade A Bushman David F Jarrard Patrick H McKenna David R Paolone Daniel H Williams IV E. Jason Abel Jyotsna Bhatnagar Sara Best Dale E Bjorling Reginald C Bruskewitz Tracy M Downs Andrew K Graf Dan R. Gralnek Sean P Hedican View MoreDr. Paul Goldenheim is a Board Member representing SEED Capital. He is trained as a pulmonary physician and is currently working as a director and consultant in the field of biotechnology, serving on the boards of directors of several companies. He has a long history in pharmaceutical research, development, and management, most recently as President of TransForm Pharmaceuticals (acquired by Johnson & Johnson) and Vice-Chairman of the Board of Directors of Hypnion (acquired by Eli Lilly). Dr. Goldenheim has authored numerous scientific publications and been an inventor on a number of pharmaceutical patents. Dr. Goldenheim also serves on the board of directors of The Big Apple Circus. He received his A.B. from Harvard College magna cum laude with highest honors in biochemical sciences and his M.D. from Harvard Medical School.
Biotechnology